Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Antitumor agent-101

😃Good
Catalog No. T79249Cas No. 2848632-52-8

Antitumor agent-101 is a selective, covalent inhibitor targeting lysine methyltransferases G9a/GLP, demonstrating IC50 values of 8.5 nM for G9a and 5.5 nM for GLP. It exhibits antitumor efficacy in the PANC-1 xenograft model [1].

Antitumor agent-101

Antitumor agent-101

😃Good
Catalog No. T79249Cas No. 2848632-52-8
Antitumor agent-101 is a selective, covalent inhibitor targeting lysine methyltransferases G9a/GLP, demonstrating IC50 values of 8.5 nM for G9a and 5.5 nM for GLP. It exhibits antitumor efficacy in the PANC-1 xenograft model [1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$1,5208-10 weeks8-10 weeks
50 mg$1,9808-10 weeks8-10 weeks
100 mg$2,5008-10 weeks8-10 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Antitumor agent-101 is a selective, covalent inhibitor targeting lysine methyltransferases G9a/GLP, demonstrating IC50 values of 8.5 nM for G9a and 5.5 nM for GLP. It exhibits antitumor efficacy in the PANC-1 xenograft model [1].
Targets&IC50
G9a:8.5 nM, GLP:5.5 nM
In vitro
Antitumor agent-101 (Compound 27) (0-5 μM; 48 hours) inhibits proliferation and colony formation in PANC-1 and MDA-MB-231 cells [1]. Furthermore, Antitumor agent-101 (0-10 μM; 0-96 hours) effectively reduces H3K9me2 levels in these cells in a concentration- and time-dependent manner.
In vivo
Antitumor agent-101 (Compound 27), administered at 2 mg/kg via intraperitoneal injection five times per week, inhibits the growth of PANC-1 xenograft tumors by suppressing the methyltransferase activity of G9a/GLP [1]. Additionally, this compound demonstrates a peak plasma concentration (Cmax) of 316 ng/mL and a mean residence time (MRT) of 0.61 hours [1].
Chemical Properties
Molecular Weight482.62
FormulaC26H38N6O3
Cas No.2848632-52-8
SmilesN(C=1C2=C(C=C(OCCCN3CCCC3)C(OC)=C2)N=C(N(C(C=C)=O)C)N1)C4CCN(C)CC4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Antitumor agent-101 | purchase Antitumor agent-101 | Antitumor agent-101 cost | order Antitumor agent-101 | Antitumor agent-101 chemical structure | Antitumor agent-101 in vivo | Antitumor agent-101 in vitro | Antitumor agent-101 formula | Antitumor agent-101 molecular weight